| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00430-010-0158-X |
| P698 | PubMed publication ID | 20445989 |
| P2093 | author name string | Axel Rethwilm | |
| P2860 | cites work | Identification of a human population infected with simian foamy viruses | Q43213940 |
| The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells | Q43792049 | ||
| Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription | Q44816872 | ||
| The complete nucleotide sequence of a New World simian foamy virus | Q45400754 | ||
| Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa | Q45749982 | ||
| Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses | Q45771507 | ||
| Gene therapy of severe combined immunodeficiencies: from mice to humans. | Q45856364 | ||
| The usefulness of a perfect parasite | Q45880398 | ||
| Macroevolution of complex retroviruses | Q46512182 | ||
| Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. | Q51214960 | ||
| Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. | Q51835443 | ||
| Isolation of a spumavirus from a sheep | Q67491800 | ||
| HIV-1 genome nuclear import is mediated by a central DNA flap | Q73726795 | ||
| Restriction of foamy viruses by APOBEC cytidine deaminases | Q24299944 | ||
| Determination of the relative amounts of Gag and Pol proteins in foamy virus particles | Q24813028 | ||
| A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles | Q24815183 | ||
| The solution structure of the simian foamy virus protease reveals a monomeric protein | Q27651022 | ||
| Properties of human foamy virus relevant to its development as a vector for gene therapy | Q28143281 | ||
| Nuclear mRNA export: insights from virology | Q28202996 | ||
| Ancient co-speciation of simian foamy viruses and primates | Q28240174 | ||
| Human foamy virus reverse transcription that occurs late in the viral replication cycle | Q28249872 | ||
| Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter | Q28263705 | ||
| Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees | Q28286256 | ||
| Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 | Q28290118 | ||
| Primate-to-human retroviral transmission in Asia | Q33219632 | ||
| Foamy viruses are unconventional retroviruses | Q33652656 | ||
| The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus | Q33676449 | ||
| The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein | Q33841186 | ||
| Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly | Q33844222 | ||
| Why aren't foamy viruses pathogenic? | Q33934207 | ||
| Foamy virus vector integration sites in normal human cells | Q34334976 | ||
| Viral late domains | Q34338672 | ||
| Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity | Q34343588 | ||
| Differential susceptibility of retroviruses to nucleoside analogues | Q34349394 | ||
| The replication strategy of foamy viruses. | Q35196120 | ||
| Foamy virus transactivation and gene expression | Q35196124 | ||
| The foamy virus envelope glycoproteins | Q35196134 | ||
| Human infection with foamy viruses. | Q35196145 | ||
| Temple monkeys and health implications of commensalism, Kathmandu, Nepal | Q36026231 | ||
| Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses. | Q36070480 | ||
| Ubiquitin-dependent virus particle budding without viral protein ubiquitination | Q36289026 | ||
| Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors | Q36362910 | ||
| Foamy virus infection in primates. | Q36548744 | ||
| Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections | Q36673204 | ||
| Characterization of the transcriptional trans activator of human foamy retrovirus | Q36689048 | ||
| Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly | Q36748004 | ||
| Interspecies transmission of simian foamy virus in a natural predator-prey system | Q36804594 | ||
| Diverse contexts of zoonotic transmission of simian foamy viruses in Asia | Q36924809 | ||
| Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors | Q36954062 | ||
| Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors | Q36985455 | ||
| Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells | Q37001945 | ||
| In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. | Q37289159 | ||
| The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region | Q37389337 | ||
| Human immunodeficiency virus as a prototypic complex retrovirus. | Q37644114 | ||
| Functional analysis of human foamy virus accessory reading frames. | Q38316300 | ||
| The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. | Q38335119 | ||
| Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type | Q38761998 | ||
| Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases | Q39525135 | ||
| Foamy virus capsids require the cognate envelope protein for particle export | Q39549687 | ||
| Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus | Q39551229 | ||
| Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. | Q39577290 | ||
| Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. | Q39580590 | ||
| Derivation and functional characterization of a consensus DNA binding sequence for the tas transcriptional activator of simian foamy virus type 1 | Q39581444 | ||
| An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity | Q39590982 | ||
| Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. | Q39602507 | ||
| A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. | Q39603094 | ||
| Foamy virus particle formation | Q39642443 | ||
| Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids | Q39684812 | ||
| Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process | Q39741951 | ||
| Formation of transient dimers by a retroviral protease | Q39742958 | ||
| Replication-competent hybrids between murine leukemia virus and foamy virus. | Q39787726 | ||
| Coinfection with HIV-1 and simian foamy virus in West Central Africans | Q39844681 | ||
| Accuracy estimation of foamy virus genome copying | Q39863795 | ||
| The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein | Q39874739 | ||
| The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains | Q39877095 | ||
| Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses | Q39877461 | ||
| Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins | Q39880036 | ||
| Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle | Q39881327 | ||
| Generation of an improved foamy virus vector by dissection of cis-acting sequences. | Q39895803 | ||
| The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions | Q39948850 | ||
| Chromatin tethering of incoming foamy virus by the structural Gag protein | Q39961265 | ||
| Retrotransposition and cell-to-cell transfer of foamy viruses | Q40011701 | ||
| Feline foamy virus genome and replication strategy. | Q40011831 | ||
| Complex effects of foamy virus central purine-rich regions on viral replication | Q40035712 | ||
| Nuclear localization of foamy virus Gag precursor protein. | Q40038468 | ||
| AZT-resistant foamy virus | Q40074663 | ||
| Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. | Q40272140 | ||
| Genome-wide mapping of foamy virus vector integrations into a human cell line | Q40294329 | ||
| Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release | Q40348017 | ||
| N-terminal Gag domain required for foamy virus particle assembly and export | Q40373857 | ||
| Analysis and function of prototype foamy virus envelope N glycosylation | Q40416439 | ||
| RNA and protein requirements for incorporation of the Pol protein into foamy virus particles | Q40423235 | ||
| Identification of domains in gag important for prototypic foamy virus egress | Q40429737 | ||
| Efficient intracellular retrotransposition of an exogenous primate retrovirus genome | Q40430005 | ||
| Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity | Q40436028 | ||
| Foamy virus integration | Q40589945 | ||
| Foamy virus--adenovirus hybrid vectors. | Q40599122 | ||
| Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection | Q40630425 | ||
| Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. | Q40651725 | ||
| Primate foamy virus Pol proteins are imported into the nucleus | Q40841228 | ||
| An active foamy virus integrase is required for virus replication | Q40947173 | ||
| Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA. | Q41163327 | ||
| The human foamy virus internal promoter is required for efficient gene expression and infectivity | Q41381054 | ||
| HIV-1 Reverse Transcription A Termination Step at the Center of the Genome | Q41443092 | ||
| Further characterization of the gapped DNA intermediates of human spumavirus: evidence for a dual initiation of plus-strand DNA synthesis | Q41693096 | ||
| AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP. | Q41878118 | ||
| HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore | Q41914326 | ||
| Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain | Q42218331 | ||
| Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors | Q42589642 | ||
| Protease-dependent uncoating of a complex retrovirus | Q42590060 | ||
| P433 | issue | 3 | |
| P921 | main subject | molecular biology | Q7202 |
| P304 | page(s) | 197-207 | |
| P577 | publication date | 2010-05-06 | |
| P1433 | published in | Medical Microbiology and Immunology | Q15760239 |
| P1476 | title | Molecular biology of foamy viruses | |
| P478 | volume | 199 |
| Q34550318 | A nuclear export signal within the structural Gag protein is required for prototype foamy virus replication |
| Q39369916 | A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors |
| Q27678148 | A unique spumavirus Gag N-terminal domain with functional properties of orthoretroviral matrix and capsid |
| Q36014113 | Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells |
| Q45354422 | Characterization and manipulation of foamy virus membrane interactions |
| Q35261679 | Converging strategies in expression of human complex retroviruses |
| Q28727984 | Drosophila errantiviruses |
| Q35798482 | Endemic Viruses of Squirrel Monkeys (Saimiri spp.). |
| Q26852372 | Evolution of foamy viruses: the most ancient of all retroviruses |
| Q90384003 | First Complete Genome Sequence of a Simian Foamy Virus Infecting the Neotropical Primate Brachyteles arachnoides |
| Q39171777 | Foamy virus-adenovirus hybrid vectors for gene therapy of the arthritides. |
| Q28584468 | Foamy-like endogenous retroviruses are extensive and abundant in teleosts |
| Q56516919 | Functional characterization of the bovine foamy virus miRNA expression cassette and its dumbbell-shaped pri-miRNA |
| Q30424469 | HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology |
| Q39316106 | Heparan sulfate is an attachment factor for foamy virus entry |
| Q35544380 | Human Pirh2 is a novel inhibitor of prototype foamy virus replication |
| Q43079609 | Identification of recombination in the envelope gene of simian foamy virus serotype 2 isolated from Macaca cyclopis |
| Q39121252 | Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction |
| Q36333631 | In Vitro Evolution of Bovine Foamy Virus Variants with Enhanced Cell-Free Virus Titers and Transmission |
| Q33798319 | Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors |
| Q39441971 | Innate sensing of foamy viruses by human hematopoietic cells |
| Q41917489 | Insights into the structure and activity of prototype foamy virus RNase H. |
| Q38786036 | Lysine residues K66, K109, and K110 in the bovine foamy virus transactivator protein are required for transactivation and viral replication |
| Q91656617 | Molecular Analysis of the Complete Genome of a Simian Foamy Virus Infecting Hylobates pileatus (pileated gibbon) Reveals Ancient Co-Evolution with Lesser Apes |
| Q39408806 | Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: different ways to counteract host-encoded restriction |
| Q33743796 | N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm |
| Q39429166 | N-terminally myristoylated feline foamy virus Gag allows Env-independent budding of sub-viral particles |
| Q28673358 | Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission |
| Q39627850 | Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. |
| Q38362470 | Origin, evolution and innate immune control of simian foamy viruses in humans |
| Q38753028 | Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication |
| Q36909603 | Population dynamics of rhesus macaques and associated foamy virus in Bangladesh. |
| Q37313583 | Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency |
| Q37685990 | Prototype foamy virus elicits complete autophagy involving the ER stress-related UPR pathway |
| Q39217498 | Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry. |
| Q37170654 | Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector |
| Q38613375 | Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer |
| Q42275220 | Structural requirements for enzymatic activities of foamy virus protease-reverse transcriptase |
| Q36187632 | Structure of a Spumaretrovirus Gag Central Domain Reveals an Ancient Retroviral Capsid |
| Q41933413 | Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors |
| Q64252108 | The Influence of Envelope C-Terminus Amino Acid Composition on the Ratio of Cell-Free to Cell-Cell Transmission for Bovine Foamy Virus |
| Q40337891 | The fourth central polypurine tract guides the synthesis of prototype foamy virus plus-strand DNA. |
| Q35015043 | Viral latency in blood and saliva of simian foamy virus-infected humans |
| Q39065035 | Viral reverse transcriptases. |
Search more.